← All Startup Schemes
Equity Startups named in eligibilityBiotech & Life Sciences
AcE

Biotechnology Innovation Fund – Accelerating Entrepreneurs

BIRAC's equity fund-of-funds for biotech — daughter funds write cheques of up to ₹7 crore, with ₹3.5 crore of follow-on.

What you get

Ticket up to ₹7 crore per startup, plus follow-on up to ₹3.5 crore

Nodal ministry

Department of Biotechnology (DBT)

Support type

Equity

Best suited for

Growth / Scaling

Typical timeline

Daughter-fund diligence cycle, typically 2–6 months

What this scheme actually is

AcE is the biotech equivalent of the Fund of Funds: BIRAC commits capital to SEBI-registered AIFs, which commit to investing twice BIRAC's contribution into biotech startups. You raise from the daughter fund, not from BIRAC. It is the natural graduation path for a company that has already been through BIG or SEED and now needs institutional venture capital.

Implementing agency: BIRAC

What the scheme sets out to do

Partner with fund managers and invest in SEBI-registered AIFs focused on biotech
Ensure daughter funds commit 2x BIRAC's contribution into biotech startups
Build a dedicated pool of venture capital for Indian life sciences

Who can apply

AcE invests in and partners with SEBI-registered Category I and II AIFs in the biotech sector
Startups and SMEs in healthcare, life sciences, pharma, biopharma, medtech, diagnostics, industrial biotech, agri-tech and bio-IT services

What you get

AcE commits up to ₹30 crore, or up to 30% of the fund corpus, in each daughter fund
Ticket size of up to ₹7 crore for an eligible startup
Provision for additional follow-on funding of up to ₹3.5 crore
Access to a fund manager with genuine life-sciences domain depth

How to apply, step by step

  1. 1

    Reach institutional readiness

    AcE daughter funds invest in companies with validated science, regulatory pathway clarity and a route to revenue. If you are pre-proof-of-concept, BIG or SEED is the right door.

  2. 2

    Identify AcE daughter funds

    BIRAC publishes the fund partners. Approach the funds whose thesis matches your sub-sector — diagnostics, medtech and biopharma have very different investor sets.

  3. 3

    Prepare the raise pack

    Deck, three-statement model, regulatory pathway and timeline, IP position, clinical or validation data, and cap table. Life-sciences diligence goes deep on regulatory risk.

  4. 4

    Run diligence and close

    Scientific, regulatory, financial and legal diligence, then term sheet and definitive documents, then the Indian company-law filings on allotment.

How Company Avenue Advisory helps

What we actually do on a AcE mandate

Financial model and valuation framing for a long-gestation, regulatory-gated business
Diligence readiness: books, IP register, grant-compliance history from BIG or SEED, statutory filings current
Cap-table management across grant, convertible and equity instruments so the round does not break on legacy terms
Post-round filings — PAS-3, valuation report, share certificates and register updates

No consultant can guarantee a sanction — that decision sits with the evaluating committee, bank or incubator. We commit to an honest eligibility view, an application built to the evaluator’s format, filing inside the window and a documented follow-up cadence. That is stated in every engagement letter we sign.

Official sources

Available Mon–Sat, 9 AM – 7 PM IST

Ready to Start Your Business Journey?

Let our Chartered Accountants handle your registrations, taxation and compliance while you focus on building your business.

✓ Free 30-min consultation✓ No hidden fees✓ Expert CAs & CSs✓ 100% digital process
Call NowWhatsApp